Yu G, Corn P, Mak C, Liang X, Zhang M, Troncoso P
Proc Natl Acad Sci U S A. 2024; 121(33):e2402903121.
PMID: 39102549
PMC: 11331113.
DOI: 10.1073/pnas.2402903121.
Lin S, Yu G, Corn P, Damasco J, Lee Y, Song J
Cancers (Basel). 2024; 16(14).
PMID: 39061241
PMC: 11274981.
DOI: 10.3390/cancers16142603.
Huang Y, Liu Z, Li M, Wang D, Ye J, Hu Q
Immun Ageing. 2024; 21(1):48.
PMID: 39026350
PMC: 11256597.
DOI: 10.1186/s12979-024-00452-1.
Xu L, Huang X, Lou Y, Xie W, He J, Yang Z
World J Surg Oncol. 2023; 21(1):391.
PMID: 38124135
PMC: 10731753.
DOI: 10.1186/s12957-023-03268-3.
Ji S, Wu W, Jiang Q
Int J Mol Sci. 2023; 24(23).
PMID: 38069225
PMC: 10707594.
DOI: 10.3390/ijms242316893.
Essential role of MFSD1-GLMP-GIMAP5 in lymphocyte survival and liver homeostasis.
Zhong X, Moresco J, Diedrich J, Pinto A, Sorelle J, Wang J
Proc Natl Acad Sci U S A. 2023; 120(50):e2314429120.
PMID: 38055739
PMC: 10723049.
DOI: 10.1073/pnas.2314429120.
The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review.
Zhang X, Jiang P, Wang C
Front Oncol. 2023; 13:1127637.
PMID: 37746292
PMC: 10513387.
DOI: 10.3389/fonc.2023.1127637.
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.
Fang J, Lu Y, Zheng J, Jiang X, Shen H, Shang X
Cell Death Dis. 2023; 14(9):586.
PMID: 37666809
PMC: 10477350.
DOI: 10.1038/s41419-023-06119-x.
Antagonizing exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt/β-catenin pathway.
Zeng F, Zhao C, Wang R, Ren L, Qiu H, Zou Z
Genes Dis. 2023; 10(4):1626-1640.
PMID: 37397518
PMC: 10311030.
DOI: 10.1016/j.gendis.2022.06.007.
The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation.
Haerinck J, Goossens S, Berx G
Nat Rev Genet. 2023; 24(9):590-609.
PMID: 37169858
DOI: 10.1038/s41576-023-00601-0.
Pathological angiogenesis: mechanisms and therapeutic strategies.
Dudley A, Griffioen A
Angiogenesis. 2023; 26(3):313-347.
PMID: 37060495
PMC: 10105163.
DOI: 10.1007/s10456-023-09876-7.
Endothelial-to-osteoblast transition in normal mouse bone development.
Lin S, Yu G, Lee Y, Song J, Song X, Zhang J
iScience. 2023; 26(2):105994.
PMID: 36798441
PMC: 9926118.
DOI: 10.1016/j.isci.2023.105994.
Alendronate conjugate for targeted delivery to bone-forming prostate cancer.
Damasco J, Yu G, Kumar A, Perez J, Lirag R, Whitley E
Talanta. 2023; 256:124308.
PMID: 36774896
PMC: 10031627.
DOI: 10.1016/j.talanta.2023.124308.
Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells.
Zhang W, Xu Z, Hao X, He T, Li J, Shen Y
Cancer Discov. 2022; 13(2):474-495.
PMID: 36287038
PMC: 9905315.
DOI: 10.1158/2159-8290.CD-22-0220.
Bone Marrow Endothelial Cells Increase Prostate Cancer Cell Apoptosis in 3D Triculture Model of Reactive Stroma.
Sablatura L, Tellman T, Kim A, Farach-Carson M
Biology (Basel). 2022; 11(9).
PMID: 36138750
PMC: 9495890.
DOI: 10.3390/biology11091271.
The road of NSCLC stem cells toward bone metastases.
Bertolini G, Roato I
Bone Rep. 2022; 17:101619.
PMID: 36110341
PMC: 9467890.
DOI: 10.1016/j.bonr.2022.101619.
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G, Corn P, Shen P, Song J, Lee Y, Lin S
Cancer Res. 2022; 82(17):3158-3171.
PMID: 35802768
PMC: 9444986.
DOI: 10.1158/0008-5472.CAN-22-0170.
Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone.
Sui L, Sanders A, Jiang W, Ye L
Comput Struct Biotechnol J. 2022; 20:2745-2758.
PMID: 35685372
PMC: 9168524.
DOI: 10.1016/j.csbj.2022.05.051.
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
Lee Y, Lin S, Yu G, Zhu M, Song J, Rivera K
Oncogene. 2021; 41(6):757-769.
PMID: 34845375
PMC: 8818031.
DOI: 10.1038/s41388-021-02131-7.
Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.
Cui J, Chen H, Zhang K, Li X
J Mol Med (Berl). 2021; 100(3):373-384.
PMID: 34821953
DOI: 10.1007/s00109-021-02159-y.